{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T13:02:42Z","timestamp":1783083762249,"version":"3.54.6"},"reference-count":8,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[1977,10,1]],"date-time":"1977-10-01T00:00:00Z","timestamp":244512000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1977,10,1]],"date-time":"1977-10-01T00:00:00Z","timestamp":244512000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[1977,10]]},"DOI":"10.1136\/ard.36.5.442","type":"journal-article","created":{"date-parts":[[2008,7,28]],"date-time":"2008-07-28T23:49:46Z","timestamp":1217288986000},"page":"442-447","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Frequency and clinical significance of antibodies to ribonucleoprotein in SLE and other connective tissue disease subgroups."],"prefix":"10.1016","volume":"36","author":[{"given":"D.M","family":"Grennan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Bunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.R","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.W","family":"Buchanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.C","family":"Dick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/S0140-6736(61)91944-4","article-title":"Variations in the morphological patterns of autoimmune nuclear fluorescence","volume":"1","author":"Beck, J.S.","year":"1961","unstructured":"Beck, J. S. (1961). Variations in the morphological patterns of autoimmune nuclear fluorescence. Lancet, 1, 1203-1205.","journal-title":"Lancet"},{"key":"ref_2","first-page":"643","article-title":"Preliminary criteria for the classification of systemic lupus erythematosus","volume":"21","author":"Cohen, A.S.; Reynolds, W.E.; Franklin, E.C.; Kulka, J.P.; Ropes, M.W.; Shulman, L.E.; Wallace, S.L.","year":"1971","unstructured":"Cohen, A. S., Reynolds, W. E., Franklin, E. C., Kulka, J. P., Ropes, M. W., Shulman, L. E., and Wallace, S. L. (1971). Preliminary criteria for the classification of systemic lupus erythematosus. Bulletin on Rheumatic Diseases, 21, 643-648.","journal-title":"Bulletin on Rheumatic Diseases"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0140-6736(71)90234-0","article-title":"Significance of anti-DNA antibodies in systemic lupus erythematosus","volume":"2","author":"Hughes, G.R.V.","year":"1971","unstructured":"Hughes, G. R. V. (1971). Significance of anti-DNA antibodies in systemic lupus erythematosus. Lancet, 2, 861-863.","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/art.1780190309","article-title":"Identification of antibodies to nuclear acidic antigens by counterimmunoelectrophoresis","volume":"19","author":"Kurata, N.; Tan, E.M.","year":"1976","unstructured":"Kurata, N., and Tan, E. M. (1976). Identification of antibodies to nuclear acidic antigens by counterimmunoelectrophoresis. Arthritis and Rheumatism, 19, 574-578.","journal-title":"Arthritis and Rheumatism"},{"key":"ref_5","first-page":"769","article-title":"Ribonucleoprotein antibodies; frequency and clinical significance in systemic lupus erythematosus, scleroderma and mixed connective tissue disease","volume":"82","author":"Parker, M.D.","year":"1973","unstructured":"Parker, M. D. (1973). Ribonucleoprotein antibodies; frequency and clinical significance in systemic lupus erythematosus, scleroderma and mixed connective tissue disease. Journal of Laboratory and Clinical Medicine, 82, 769-775.","journal-title":"Journal of Laboratory and Clinical Medicine"},{"key":"ref_6","first-page":"148","article-title":"Mixed connective tissue diseasean apparently distinct rheumatic disease syndrome associated with a specific antibody to extractable nuclear antigen (ENA)","volume":"52","author":"Sharp, G.C.; Irvin, W.S.; Tan, E.M.; Gould, R.G.; Holman, H.R.","year":"1972","unstructured":"Sharp, G. C., Irvin, W. S., Tan, E. M., Gould, R. G., and Holman, H. R. (1972). Mixed connective tissue diseasean apparently distinct rheumatic disease syndrome associated with a specific antibody to extractable nuclear antigen (ENA). American Journal ofMedicine, 52, 148-161.","journal-title":"American Journal ofMedicine"},{"key":"ref_7","article-title":"Sjogren's syndrome","author":"Whaley, K.; Williamson, J.; Chisholm, D.M.; Webb, J.; Mason, D.K.; Buchanan, W.W.","year":"1973","unstructured":"Whaley, K., Williamson, J., Chisholm, D. M., Webb, J., Mason, D. K., and Buchanan, W. W. (1973). Sjogren's syndrome."},{"key":"ref_8","first-page":"279","volume":"42","author":"components, Sicca","unstructured":"Sicca components. Quarterly Journal of Medicine, 42, 279-302.","journal-title":"Quarterly Journal of Medicine"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724407188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724407188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.36.5.442","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T11:46:05Z","timestamp":1737546365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724407188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1977,10]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1977,10]]}},"alternative-id":["S0003496724407188"],"URL":"https:\/\/doi.org\/10.1136\/ard.36.5.442","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[1977,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Frequency and clinical significance of antibodies to ribonucleoprotein in SLE and other connective tissue disease subgroups.","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.36.5.442","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1977 \u00a9 THE AUTHORS. Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology, EULAR. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}